Medical Prop SEC Filings

Medical Properties Trust, Inc. (MPW) insider filing shows that on 10/07/2025 a reporting person had 6,956 shares of common stock withheld at a price of $5.01 to satisfy tax withholding upon vesting of restricted stock. This action is recorded as a disposition code F but the form explains the withholding "does not constitute a sale transaction." After the withholding, the reporting person beneficially owns 481,691 shares directly. The form was filed by one reporting person who serves as SVP, Senior Advisor to the CEO.

Insider withholding on restricted shares at Medical Properties Trust (MPW) — The form reports that Kevin Hanna, Senior VP, Controller & CAO, had 5,663 shares of common stock withheld on 10/07/2025 to satisfy tax withholding obligations tied to vesting of restricted stock. The transaction is coded F and is explicitly noted as not constituting a sale.

After the withholding, the reporting person beneficially owned 443,568 shares. The filing was submitted by power of attorney W. Zachary Riddle. The record shows routine tax withholding at vesting and continued substantial beneficial ownership without open-market disposition.

Medical Properties Trust, Inc. (MPW) reported an insider withholding of restricted stock to satisfy tax obligations. On 10/07/2025, the reporting person, Hooper Rosa Handley, identified as SVP of Operations and an officer, had 3,561 shares of common stock withheld at a price of $5.01. The filing uses transaction code F, and the form clarifies this withholding "does not constitute a sale transaction." After the withholding, the reporting person beneficially owns 397,182 shares directly.

Medical Properties Trust, Inc. (MPW) reporting person R. Steven Hamner disclosed a Form 4 filing showing withholding of 35,776 common shares on 10/07/2025 to satisfy tax withholding upon vesting of restricted stock; the filing states this withholding is not a sale. The shares were valued at $5.01 per share for the withholding calculation. After the withholding, the reporting person beneficially owns 2,949,742 shares directly. The filing identifies Mr. Hamner as both a director and the company’s Executive Vice President & CFO. The Form 4 was signed via power of attorney on 10/07/2025.

Director and SVP of Finance Charles R. Lambert reported a transaction dated 10/07/2025 affecting his holdings in Medical Properties Trust, Inc. (MPW). The filing shows 3,628 shares of common stock were reported with transaction code F and listed as disposed (D) at a price of $5.01 per share, leaving 320,237 shares beneficially owned after the reported transaction.

The form clarifies these shares were withheld upon vesting of restricted stock to satisfy tax withholding obligations, and the filer states this withholding "does not constitute a sale transaction." The filing was submitted by power of attorney on 10/07/2025.

Medical Properties Trust insider share grants and vesting details

SVP of Operations Rosa Handley was granted two non‑cash awards on 09/24/2025: 36,765 shares that vest quarterly through March 31, 2028 and 15,420 performance‑based shares tied to three‑year total shareholder return (TSR) hurdles through April 14, 2028. The performance shares pay out 100% at 20% TSR, 200% at 40% TSR and 300% at 60% TSR with linear interpolation for intermediate results; earned shares vest quarterly over one year or immediately upon final committee determination. Reported beneficial ownership after transactions is 400,743 shares (direct).

Insider grant and ownership change at Medical Properties Trust (MPW). Larry H. Portal, SVP and Senior Advisor to the CEO, was reported as acquiring two equity awards on 09/24/2025. One grant of 59,743 common shares vests quarterly through March 31, 2028 and increased his beneficial ownership to 463,589 shares. A second performance-based grant of 25,058 shares is contingent on three-year total shareholder return (TSR) hurdles through April 14, 2028 (20% TSR = 100% payout; 40% = 200%; 60% = 300%); if earned, those shares vest in equal quarterly installments over the following year or in full upon final Compensation Committee determination, subject to continued employment. The Form 4 was filed 09/26/2025 and signed by a power of attorney.

Insider purchases and performance awards at Medical Properties Trust (MPW) The report shows that Kevin James Hanna, Senior VP, Controller & CAO, was granted and acquired a total of 84,801 shares of MPW common stock on 09/24/2025 through two separate awards: 59,743 time-vested shares that vest quarterly through March 31, 2028, and 25,058 performance-based shares tied to three-year total shareholder return (TSR) hurdles ending April 14, 2028. Following these transactions, the reporting person beneficially owns 449,231 shares in total. The performance award vests only if TSR targets (20%, 40%, 60%) are met, with potential upside up to 300% of the target award and post-performance quarterly vesting or earlier full vesting upon final committee determination.

Medical Properties Trust, Inc. filed a prospectus supplement dated August 11, 2025 establishing an at-the-market equity program to offer up to $500,000,000 of common stock (NYSE: MPW). The offering is being conducted under an equity distribution agreement with multiple investment banks that may act as agents, forward sellers or principals, and the agents may receive up to 2% in commissions. The supplement states the last reported NYSE sale price was $4.08 per share on August 8, 2025.

The company intends to contribute net proceeds to its operating partnership for general corporate purposes, including repayment of borrowings under its revolving credit and term loan facilities and acquiring healthcare properties. MPT reported a portfolio of 392 properties leased or loaned to 53 tenants as of June 30, 2025 (174 general acute care hospitals, 69 behavioral health, 128 post-acute, 21 freestanding ER/urgent care), with ~4% in development or not leased and no single property >2% of total assets. The prospectus highlights material risks: potential dilution from forward sale transactions, substantial cash payment obligations on cash settlement, uncertain U.S. federal tax treatment of cash-settled forwards (with potential REIT qualification implications), recent dividend reductions in 2024 and 2025, and ownership restrictions capped at 9.8% to preserve REIT status.